Bridgewater Associates Portfolio holdings
Bridgewater Associates, founded in 1975 by Ray Dalio in New York and now headquartered in Westport, Connecticut, is the world’s largest hedge fund, managing over $125 billion in assets as of late 2024, serving institutional clients like pension funds, endowments, and sovereign wealth funds. Known for its pioneering "Pure Alpha" and "All Weather" strategies, the firm uses a systematic, macroeconomic approach to deliver uncorrelated returns and risk parity across global markets, including equities, bonds, currencies, and commodities, guided by rigorous data analysis and radical transparency. Dalio, who stepped down as co-CIO in 2022, built a unique culture of "radical truth" and "thoughtful disagreement," documented in his book *Principles*, though the firm transitioned leadership to co-CEOs Nir Bar Dea and Mark Bertolini in 2023 amid succession planning. With around 1,300 employees and a history of navigating crises like 2008 with gains, Bridgewater remains a titan in alternative investments, blending intellectual rigor with a distinctive, often polarizing management philosophy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$253M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$149M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
GE Aerospace
GE
|
+$22.3M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$22.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$19.9M |
| 3 |
Cisco
CSCO
|
+$14M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$11.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$9.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.04% |
| 2 | Energy | 2.47% |
| 3 | Materials | 1.34% |
| 4 | Industrials | 0.97% |
| 5 | Consumer Discretionary | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLR
101
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.26M | 0.04% |
66,600
| – | – |
|
102
Regeneron Pharmaceuticals
REGN
$68.8B
| $5.2M | 0.04% |
+18,400
| New | +$5.45M |
|
103
DuPont de Nemours
DD
$18.6B
| $5.18M | 0.04% |
39,720
+29,616
| +293% | +$3.77M |
|
104
Weyerhaeuser
WY
$17.3B
| $5.15M | 0.04% |
155,666
-25,400
| -14% | -$768K |
|
|
MRO
105
DELISTED
Marathon Oil Corporation
MRO
| $5.15M | 0.04% |
128,900
| – | – |
|
106
Kohl's
KSS
$2.03B
| $5.14M | 0.04% |
+97,651
| New | +$5.29M |
|
107
Range Resources
RRC
$9.11B
| $5.12M | 0.04% |
58,866
+28,966
| +97% | +$2.59M |
|
|
NBL
108
DELISTED
Noble Energy, Inc.
NBL
| $5.02M | 0.04% |
64,852
| – | – |
|
109
MetLife
MET
$61B
| $5.01M | 0.04% |
101,276
+12,678
| +14% | +$593K |
|
110
Parker-Hannifin
PH
$125B
| $5M | 0.04% |
39,726
+6,100
| +18% | +$760K |
|
|
VMW
111
DELISTED
VMware, Inc
VMW
| $4.99M | 0.04% |
51,500
+16,900
| +49% | +$1.64M |
|
|
PTR
112
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $4.97M | 0.04% |
39,597
+1,500
| +4% | +$177K |
|
113
Procter & Gamble
PG
$343B
| $4.94M | 0.04% |
+62,831
| New | +$5.07M |
|
114
Eldorado Gold
EGO
$8.31B
| $4.76M | 0.04% |
124,200
+8,480
| +7% | +$260K |
|
|
POT
115
DELISTED
Potash Corp Of Saskatchewan
POT
| $4.73M | 0.04% |
+124,100
| New | +$4.48M |
|
116
United Rentals
URI
$71.1B
| $4.67M | 0.04% |
44,626
-41,474
| -48% | -$4.05M |
|
|
IPG
117
DELISTED
Interpublic Group of Companies
IPG
| $4.61M | 0.03% |
+236,247
| New | +$4.29M |
|
118
Royal Gold
RGLD
$17.1B
| $4.32M | 0.03% |
56,800
+4,000
| +8% | +$264K |
|
119
International Paper
IP
$22.3B
| $4.32M | 0.03% |
91,610
+12,239
| +15% | +$537K |
|
120
Northrop Grumman
NOC
$77B
| $4.27M | 0.03% |
35,688
+1,900
| +6% | +$230K |
|
|
HOT
121
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $4.25M | 0.03% |
52,523
-400
| -0.8% | -$31.4K |
|
122
Wynn Resorts
WYNN
$10.1B
| $4.22M | 0.03% |
20,314
-21,191
| -51% | -$4.39M |
|
123
Kinross Gold
KGC
$28.5B
| $4.21M | 0.03% |
1,015,500
+100,100
| +11% | +$407K |
|
124
GameStop
GME
$9.5B
| $4.12M | 0.03% |
+407,600
| New | +$3.99M |
|
|
ALXN
125
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.11M | 0.03% |
26,332
-24,039
| -48% | -$3.8M |
|
Similar funds
Bridgewater Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Bridgewater Associates held 404 positions worth $13.3B, up 9.2% from $12.2B the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Bridgewater Associates deployed $438M of net new capital in Q2 2014, opening 65 new positions and adding to 128 existing holdings. Its largest new stake was Bed Bath & Beyond Inc: 255,200 shares worth $14.6M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, up from 2.6% a quarter earlier, followed by Energy and Materials.
On the sell side, the largest reduction was Gen Digital, an estimated $22.1M trimmed.
- Bridgewater Associates's largest Q2 2014 buy was Bed Bath & Beyond Inc: 255,200 shares worth $14.6M.
- Bridgewater Associates added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $253M increase.
- Bridgewater Associates's biggest Q2 2014 reduction was Gen Digital, cutting an estimated $22.1M.
- Bridgewater Associates fully exited Berkshire Hathaway Class B in Q2 2014, selling an estimated $11.7M.
- Bridgewater Associates's ten largest holdings make up 90% of its $13.3B portfolio in Q2 2014.
- Bridgewater Associates opened 65 new positions and closed 101 in Q2 2014.
- Bridgewater Associates's portfolio value rose 9.2% quarter-over-quarter to $13.3B.
Based on Bridgewater Associates's 13F filing for Q2 2014, filed 12 Aug 2014.